NCNMGF
INTS icon

Nano-Cap New Millennium Growth Fund’s Intensity Therapeutics INTS Stock Holding History

Nano-Cap New Millennium Growth Fund’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Hold
25,000
– – 0.08% 122
2026
Q1 		$147K Buy
+25,000
New +$204K 0.14% 124

Other funds holding INTS

KWM
KMT Wealth Management El Segundo, California $118M AUM 26.19% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Nano-Cap New Millennium Growth Fund's INTS Position: Q2 2026 in Review

Nano-Cap New Millennium Growth Fund held its Intensity Therapeutics (INTS) position steady in Q2 2026 at 25,000 shares worth $103K. The position accounts for 0.08% of the portfolio, ranked #122.

Nano-Cap New Millennium Growth Fund first reported a position in INTS in Q1 2026 and has held it in 2 quarters since. The position peaked at $147K in Q1 2026. 16 funds tracked by Wall St. Rank hold INTS as of Q2 2026.

  • Nano-Cap New Millennium Growth Fund held 25,000 shares of Intensity Therapeutics worth $103K as of Q2 2026.
  • Nano-Cap New Millennium Growth Fund left its Intensity Therapeutics share count unchanged in Q2 2026.
  • Intensity Therapeutics made up 0.08% of Nano-Cap New Millennium Growth Fund's portfolio in Q2 2026, its #122 holding.
  • Nano-Cap New Millennium Growth Fund first reported a position in Intensity Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Nano-Cap New Millennium Growth Fund's Intensity Therapeutics position peaked at $147K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q2 2026.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q2 2026, filed 14 Aug 2026.